Antibiotic Portfolio:

Our commitment to the field of infectious disease is an active one with a promising product pipeline of new therapeutic compounds and treatment options for difficult-to-treat conditions. We are expanding the knowledge base of this therapeutic area and empowering physicians to make evidence-based clinical decisions. Working with the brightest and the best allows us to generate and publish key information on our advances.

Products:

                   [popup_anything id=”248″]      [popup_anything id=”245″]

[popup_anything id=”321″] [popup_anything id=”312″]

[popup_anything id=”305″] [popup_anything id=”299″]

[popup_anything id=”242″]    [popup_anything id=”239″]

[popup_anything id=”236″] [popup_anything id=”224″]

[popup_anything id=”218″]  [popup_anything id=”215″]

[popup_anything id=”199″] [popup_anything id=”198″]

[popup_anything id=”151″] [popup_anything id=”201″]

[popup_anything id=”203″] [popup_anything id=”233″]